Biggest increases in specialty drug costs seen in rheumatologic, cancer, and hemophilia agents.
View on PubMed
Sorry, we couldn't extract any citations for this paper.
Sorry, we couldn't extract any references for this paper.
Loading similar papers…
Presentations referencing similar topics
Specialty Drugs : Managing Costs & Ensuring Access
Chuck Shih • Jun 02, 2018
Players in Hemophilia Care in Canada
Jan 07, 2016
Macromolecules in drug delivery Macromolecular targeting agents , carriers , and drugs
Aug 30, 2017